Surgical treatment of refractory epilepsy after chemotherapy in two children with leukemia()

Por Leng, Yun, Yu, Tao, Li, Yongjie, Chen, Wenming
Publicado em 2013

Positive transcription elongation factor b (P-TEFb) is a therapeutic target in human multiple myeloma

Por Zhang, Yu, Zhou, Liang, Leng, Yun, Dai, Yun, Orlowski, Robert Z., Grant, Steven
Publicado no Oncotarget (2017)

Arsenic trioxide potentiates sensitivity of multiple myeloma cells to lenalidomide by upregulating cereblon expression levels

Por Jian, Yuan, Gao, Wen, Geng, Chuanying, Zhou, Huixing, Leng, Yun, Li, Yanchen, Chen, Wenming
Publicado no Oncol Lett (2017)

Retrospective analysis of 264 multiple myeloma patients

Por GENG, CHUANYING, LIU, NIAN, YANG, GUANGZHONG, LIU, AIJUN, LENG, YUN, WANG, HUIJUAN, LI, LIHONG, WU, YIN, LI, YANCHEN, CHEN, WENMING
Publicado em 2013

Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma

Por Leng, Yun, Qiu, Lugui, Hou, Jian, Zhao, Yaozhong, Zhang, Xuejun, Yang, Shifang, Xi, Hao, Huang, Zhongxia, Pan, Ling, Chen, Wenming
Publicado no Chin J Cancer (2016)

Targeting SQSTM1/p62 Induces Cargo Loading Failure and Converts Autophagy to Apoptosis via NBK/Bik

Por Chen, Shuang, Zhou, Liang, Zhang, Yu, Leng, Yun, Pei, Xin-Yan, Lin, Hui, Jones, Richard, Orlowski, Robert Z., Dai, Yun, Grant, Steven
Publicado em 2014

A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis

Por Chen, Shuang, Zhang, Yu, Zhou, Liang, Leng, Yun, Lin, Hui, Kmieciak, Maciej, Pei, Xin-Yan, Jones, Richard, Orlowski, Robert Z., Dai, Yun, Grant, Steven
Publicado em 2014

A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations

Por Zhou, Liang, Zhang, Yu, Chen, Shuang, Kmieciak, Maciej, Leng, Yun, Lin, Hui, Rizzo, Kathryn A., Dumur, Catherine I., Ferreira-Gonzalez, Andrea, Dai, Yun, Grant, Steven
Publicado no Leukemia (2014)

The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR

Por Zhou, Liang, Chen, Shuang, Zhang, Yu, Kmieciak, Maciej, Leng, Yun, Li, Lihong, Lin, Hui, Rizzo, Kathryn A., Dumur, Catherine I., Ferreira-Gonzalez, Andrea, Rahmani, Mohamed, Povirk, Lawrence, Chalasani, Sri, Berger, Allison J., Dai, Yun, Grant, Steven
Publicado no Blood (2016)